Detalles de la búsqueda
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048793
2.
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 403(10434): 1341-1350, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521086
3.
Survival prediction in patients with gynecological cancer irradiated for brain metastases.
Acta Oncol
; 63: 206-212, 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647023
4.
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life.
Acta Obstet Gynecol Scand
; 103(2): 387-395, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991142
5.
Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study.
Acta Obstet Gynecol Scand
; 103(4): 669-683, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37694965
6.
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma.
Gynecol Oncol
; 176: 76-81, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478615
7.
Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer.
Int J Gynecol Cancer
; 33(8): 1279-1286, 2023 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451690
8.
Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer.
Int J Gynecol Cancer
; 33(12): 1898-1905, 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000795
9.
Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients.
Int J Gynecol Cancer
; 33(8): 1287-1294, 2023 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451689
10.
Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
Cancer
; 128(16): 3080-3089, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714310
11.
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.
Gynecol Oncol
; 167(3): 452-457, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36243601
12.
Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study.
Psychooncology
; 31(2): 298-305, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516040
13.
Early referral to a palliative team improves end-of-life care among gynecological cancer patients: a retrospective, population-based study.
Int J Gynecol Cancer
; 32(2): 181-188, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987096
14.
Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer.
Acta Obstet Gynecol Scand
; 101(3): 313-322, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964982
15.
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
Am J Obstet Gynecol
; 225(4): 407.e1-407.e16, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019887
16.
The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness.
Acta Oncol
; 60(4): 434-443, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651647
17.
Self-management and adherence to recommended follow-up after gynaecological cancer: results from the international InCHARGE study.
Int J Gynecol Cancer
; 31(8): 1106-1115, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33858949
18.
Association of patient-reported outcomes and ovarian cancer recurrence.
Int J Gynecol Cancer
; 31(9): 1248-1259, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34489355
19.
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol.
Int J Gynecol Cancer
; 30(9): 1444-1449, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586892
20.
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer
; 30(12): 1997-2001, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606097